位置:首页 > 蛋白库 > IGE_HUMAN
IGE_HUMAN
ID   IGE_HUMAN               Reviewed;         547 AA.
AC   P0DOX4;
DT   15-MAR-2017, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2017, sequence version 1.
DT   03-AUG-2022, entry version 20.
DE   RecName: Full=Immunoglobulin epsilon heavy chain {ECO:0000305};
DE   AltName: Full=Immunoglobulin epsilon heavy chain ND {ECO:0000305|Ref.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   PROTEIN SEQUENCE, PYROGLUTAMATE FORMATION AT GLN-1, DISULFIDE BOND, AND
RP   GLYCOSYLATION AT ASN-145; ASN-173; ASN-219; ASN-265; ASN-371; ASN-383 AND
RP   ASN-394.
RA   Bennich H.H., Johansson S.G.O., von Bahr-Lindstroem H.;
RL   (In) Bach M.K. (eds.);
RL   Immediate hypersensitivity: modern concepts and developments, pp.1-36,
RL   Marcel Dekker, New York (1978).
RN   [2]
RP   REVIEW ON SOMATIC HYPERMUTATION.
RX   PubMed=17576170; DOI=10.1146/annurev.genet.41.110306.130340;
RA   Teng G., Papavasiliou F.N.;
RT   "Immunoglobulin somatic hypermutation.";
RL   Annu. Rev. Genet. 41:107-120(2007).
RN   [3]
RP   REVIEW ON IMMUNOGLOBULINS.
RX   PubMed=20176268; DOI=10.1016/j.jaci.2009.09.046;
RA   Schroeder H.W. Jr., Cavacini L.;
RT   "Structure and function of immunoglobulins.";
RL   J. Allergy Clin. Immunol. 125:S41-S52(2010).
RN   [4]
RP   REVIEW ON FUNCTION.
RX   PubMed=22158414; DOI=10.1038/nri3128;
RA   McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L.;
RT   "Molecular programming of B cell memory.";
RL   Nat. Rev. Immunol. 12:24-34(2012).
CC   -!- FUNCTION: Immunoglobulins, also known as antibodies, are membrane-bound
CC       or secreted glycoproteins produced by B lymphocytes. In the recognition
CC       phase of humoral immunity, the membrane-bound immunoglobulins serve as
CC       receptors which, upon binding of a specific antigen, trigger the clonal
CC       expansion and differentiation of B lymphocytes into immunoglobulins-
CC       secreting plasma cells. Secreted immunoglobulins mediate the effector
CC       phase of humoral immunity, which results in the elimination of bound
CC       antigens (PubMed:22158414, PubMed:20176268). The antigen binding site
CC       is formed by the variable domain of one heavy chain, together with that
CC       of its associated light chain. Thus, each immunoglobulin has two
CC       antigen binding sites with remarkable affinity for a particular
CC       antigen. The variable domains are assembled by a process called V-(D)-J
CC       rearrangement and can then be subjected to somatic hypermutations
CC       which, after exposure to antigen and selection, allow affinity
CC       maturation for a particular antigen (PubMed:20176268, PubMed:17576170).
CC       {ECO:0000303|PubMed:17576170, ECO:0000303|PubMed:20176268,
CC       ECO:0000303|PubMed:22158414}.
CC   -!- SUBUNIT: Immunoglobulins are composed of two identical heavy chains and
CC       two identical light chains; disulfide-linked.
CC       {ECO:0000303|PubMed:20176268}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:20176268,
CC       ECO:0000303|PubMed:22158414}. Cell membrane
CC       {ECO:0000303|PubMed:20176268, ECO:0000303|PubMed:22158414}.
CC   -!- CAUTION: This sequence is an example of a full-length immunoglobulin
CC       epsilon heavy chain. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; P0DOX4; -.
DR   SMR; P0DOX4; -.
DR   iPTMnet; P0DOX4; -.
DR   PhosphoSitePlus; P0DOX4; -.
DR   jPOST; P0DOX4; -.
DR   PRIDE; P0DOX4; -.
DR   Pharos; P0DOX4; Tdark.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0019814; C:immunoglobulin complex; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07654; C1-set; 4.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00407; IGc1; 4.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   PROSITE; PS50835; IG_LIKE; 5.
DR   PROSITE; PS00290; IG_MHC; 3.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Cell membrane; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Immunity; Immunoglobulin;
KW   Immunoglobulin domain; Membrane; Pyrrolidone carboxylic acid; Repeat;
KW   Secreted.
FT   CHAIN           1..547
FT                   /note="Immunoglobulin epsilon heavy chain"
FT                   /id="PRO_0000439285"
FT   DOMAIN          1..120
FT                   /note="Ig-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          130..223
FT                   /note="Ig-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          232..329
FT                   /note="Ig-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          333..437
FT                   /note="Ig-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          443..542
FT                   /note="Ig-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   REGION          1..124
FT                   /note="Variable (V) domain, involved in antigen
FT                   recognition"
FT                   /evidence="ECO:0000305"
FT   REGION          125..547
FT                   /note="Constant (C) domain"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         1
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        145
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        173
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        219
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        371
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   CARBOHYD        383
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        22..96
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        138
FT                   /note="Interchain (with a light chain)"
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        139..225
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        153..207
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        241
FT                   /note="Interchain (with a heavy chain)"
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        254..312
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        328
FT                   /note="Interchain (with a heavy chain)"
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        358..418
FT                   /evidence="ECO:0000269|Ref.1"
FT   DISULFID        464..524
FT                   /evidence="ECO:0000269|Ref.1"
SQ   SEQUENCE   547 AA;  60323 MW;  865E343B2D159BA6 CRC64;
     QVQLVQSGAE VRKPGASVRV SCKASGYTFI DSYVGWIRQA PGHGLEWIHW INPNSGGTNY
     APRFQGRVTM TRDASFSTAY MDLRSLRSDD SAVFYCAKSD PFWSDYNFDY SSSEEGTEVT
     YTVSGAWTLP SVFPLTRCCK NIPSNATSVT LGCLATGYFP EPVMVTWDTG SLNGTTLPAT
     TLTLSGHYAT ISLLTVSGAW AKQMFTCRVA HTPSSTVDNK TFSVCSRDFT PPTVKILQSS
     CDGLGHFPPT IQLCLVSGYT PGTINITWLE DGQVMDVDLS TASTESQGEL ASTESQLTLS
     QKHWLSDRTY TCQVTYQGHT FQDSTKKCAD SNPRGVSAYL SRPSPFDLFI RKSPTITCLV
     VDLAPSKGTV NLTWSRASGK PVNHSTRKEE KQRNGTLTVT STLPVGTRDW IEGETYQCRV
     THPHLPRALM RSTTKTSGPR AAPEVYAFAT PEWPGSRDKR TLACLIQNFM PEDISVQWLH
     NEVQLPDARH STTQPRKTKG SGFFVFSRLE VTRAEWQEKD EFICRAVHEA ASPSQTVQRA
     VSVNPGK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024